1-231352778-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032018.7(SPRTN):​c.887C>T​(p.Pro296Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.615 in 1,613,562 control chromosomes in the GnomAD database, including 307,696 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 25827 hom., cov: 32)
Exomes 𝑓: 0.62 ( 281869 hom. )

Consequence

SPRTN
NM_032018.7 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.149

Publications

49 publications found
Variant links:
Genes affected
SPRTN (HGNC:25356): (SprT-like N-terminal domain) The protein encoded by this gene may play a role in DNA repair during replication of damaged DNA. This protein recruits valosin containing protein (p97) to stalled DNA replication forks where it may prevent excessive translesional DNA synthesis and limit the number of DNA-damage induced mutations. It may also be involved in replication-related G2/M-checkpoint regulation. Deficiency of a similar protein in mouse causes chromosomal instability and progeroid phenotypes. Mutations in this gene have been associated with Ruijs-Aalfs syndrome (RJALS). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
SPRTN Gene-Disease associations (from GenCC):
  • progeroid features-hepatocellular carcinoma predisposition syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.410465E-6).
BP6
Variant 1-231352778-C-T is Benign according to our data. Variant chr1-231352778-C-T is described in ClinVar as Benign. ClinVar VariationId is 1333158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.636 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPRTNNM_032018.7 linkc.887C>T p.Pro296Leu missense_variant Exon 5 of 5 ENST00000295050.12 NP_114407.3 Q9H040-1A0A024R3U2
SPRTNXM_006711818.4 linkc.758C>T p.Pro253Leu missense_variant Exon 4 of 4 XP_006711881.1
SPRTNNM_001010984.4 linkc.*1172C>T 3_prime_UTR_variant Exon 4 of 4 NP_001010984.1 Q9H040-2
SPRTNNM_001261462.3 linkc.*1172C>T 3_prime_UTR_variant Exon 3 of 3 NP_001248391.1 Q9H040-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPRTNENST00000295050.12 linkc.887C>T p.Pro296Leu missense_variant Exon 5 of 5 1 NM_032018.7 ENSP00000295050.7 Q9H040-1
SPRTNENST00000391858.8 linkc.*1172C>T 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000375731.4 Q9H040-2
SPRTNENST00000366644.3 linkc.*14C>T downstream_gene_variant 5 ENSP00000355604.3 B1AKT1
SPRTNENST00000469904.1 linkn.*24C>T downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.577
AC:
87729
AN:
151960
Hom.:
25817
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.453
Gnomad AMI
AF:
0.638
Gnomad AMR
AF:
0.550
Gnomad ASJ
AF:
0.591
Gnomad EAS
AF:
0.553
Gnomad SAS
AF:
0.558
Gnomad FIN
AF:
0.700
Gnomad MID
AF:
0.637
Gnomad NFE
AF:
0.641
Gnomad OTH
AF:
0.593
GnomAD2 exomes
AF:
0.597
AC:
149561
AN:
250474
AF XY:
0.601
show subpopulations
Gnomad AFR exome
AF:
0.451
Gnomad AMR exome
AF:
0.506
Gnomad ASJ exome
AF:
0.590
Gnomad EAS exome
AF:
0.574
Gnomad FIN exome
AF:
0.689
Gnomad NFE exome
AF:
0.643
Gnomad OTH exome
AF:
0.604
GnomAD4 exome
AF:
0.619
AC:
904266
AN:
1461482
Hom.:
281869
Cov.:
58
AF XY:
0.618
AC XY:
449183
AN XY:
727036
show subpopulations
African (AFR)
AF:
0.444
AC:
14869
AN:
33458
American (AMR)
AF:
0.513
AC:
22926
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.586
AC:
15288
AN:
26110
East Asian (EAS)
AF:
0.557
AC:
22113
AN:
39684
South Asian (SAS)
AF:
0.561
AC:
48320
AN:
86200
European-Finnish (FIN)
AF:
0.689
AC:
36778
AN:
53386
Middle Eastern (MID)
AF:
0.665
AC:
3837
AN:
5768
European-Non Finnish (NFE)
AF:
0.633
AC:
703755
AN:
1111846
Other (OTH)
AF:
0.603
AC:
36380
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
19907
39814
59722
79629
99536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18544
37088
55632
74176
92720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.577
AC:
87773
AN:
152080
Hom.:
25827
Cov.:
32
AF XY:
0.581
AC XY:
43160
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.452
AC:
18753
AN:
41452
American (AMR)
AF:
0.550
AC:
8411
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.591
AC:
2051
AN:
3472
East Asian (EAS)
AF:
0.553
AC:
2863
AN:
5178
South Asian (SAS)
AF:
0.559
AC:
2696
AN:
4820
European-Finnish (FIN)
AF:
0.700
AC:
7403
AN:
10580
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.641
AC:
43579
AN:
67982
Other (OTH)
AF:
0.591
AC:
1248
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1898
3796
5693
7591
9489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.610
Hom.:
78043
Bravo
AF:
0.561
TwinsUK
AF:
0.646
AC:
2395
ALSPAC
AF:
0.638
AC:
2458
ESP6500AA
AF:
0.468
AC:
2061
ESP6500EA
AF:
0.636
AC:
5473
ExAC
AF:
0.598
AC:
72619
Asia WGS
AF:
0.558
AC:
1939
AN:
3478
EpiCase
AF:
0.637
EpiControl
AF:
0.629

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Progeroid features-hepatocellular carcinoma predisposition syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SPRTN-related disorder Benign:1
Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
6.7
DANN
Benign
0.27
DEOGEN2
Benign
0.022
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.0000024
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.73
N
PhyloP100
0.15
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.039
Sift
Benign
0.29
T
Sift4G
Benign
0.21
T
Polyphen
0.0
B
Vest4
0.014
MPC
0.019
ClinPred
0.0071
T
GERP RS
1.3
Varity_R
0.019
gMVP
0.60
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2437150; hg19: chr1-231488524; COSMIC: COSV50478309; COSMIC: COSV50478309; API